Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 29, 2009

Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab

  • Proven Diagnostics will provide select diagnostic tools from Berkeley HeartLab’s (BHL) menu of cardiovascular tests and services. The co-marketing agreement includes BHL’s 4myheart cardiovascular disease management program. 

    Proven Diagnostics will be the first external clinical laboratory to have access to KIF6, BHL’s genetic test. The KIF6 gene encodes kinesin-like protein 6 (KIF6), which is thought to be associated with cardiovascular risk and statin benefit. Testing under the agreement will be performed by BHL.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »